BFRA - Biofrontera AG

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

Currency in EUR. All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
25,614
21,107
12,025
6,130
4,138
Cost of Revenue
5,862
4,451
1,715
1,652
1,236
Gross Profit
19,751
16,656
10,310
4,478
2,902
Operating Expenses
Research Development
4,423
4,427
4,225
4,640
6,204
Selling General and Administrative
43,509
30,707
20,019
11,616
6,929
Total Operating Expenses
47,932
35,134
24,244
16,257
13,133
Operating Income or Loss
-28,181
-18,478
-13,934
-11,779
-10,231
Interest Expense
3,006
1,784
1,133
1,207
1,169
Total Other Income/Expenses Net
21,247
969
-1,073
2,404
187
Income Before Tax
-9,541
-19,269
-16,102
-10,579
-11,203
Income Tax Expense
-10,370
-10,391
0
0
0
Income from Continuing Operations
829
-8,878
-16,102
-10,579
-11,203
Net Income
585
-8,878
-16,102
-10,579
-11,203
Net Income available to common shareholders
585
-8,878
-16,102
-10,579
-11,203
Reported EPS
Basic
-
-0.40
-0.80
-0.69
-0.80
Diluted
-
-0.40
-0.80
-0.69
-0.80
Weighted average shares outstanding
Basic
-
21,848
19,983
15,610
13,958
Diluted
-
21,848
19,983
15,610
13,958
EBITDA
-
-16,731
-14,085
-8,541
-9,223